This is the 12th DIA Middle East Regulatory Conference (MERC) in partnership with the Middle East Regulatory Network (MERN). The conference will bring together most authorities from the Middle East region and discuss the hot topics in the region, such as serialisation and life cycle management. Recent developments at country-level are also discussed. This conference is one of its kind and takes place biennially. It has grown rapidly over the past years and early registration is recommended.
Our Middle East Regulatory Conference programme committee, pulled together their thoughts on regulatory progress made in countries across the region. Examples include: Issue of fast track regulation in Egypt, and Update on pricing regulations in Lebanon. View Infographic
The programme is under development and will be updated frequently. We recommend visiting the page for updates.
Who should attend?
The conference offers the opportunity for key stakeholders active or interested in this diverse and changing region, including representatives from regulatory agencies, ministries of health, local and multi-national pharmaceutical companies, to meet to exchange views, discuss topics of interest and identify actions to increase patient access to new and improved medicines and therapies.
Kerstin Ahrendt-Soelter • Director Regulatory Affairs International
Biotest AG, Germany
Donia Al Bastaki • Head of Registration Department, Pharmaceutical & Herbal Medicines Registration
Ministry of Health, Drug and Food Control, Kuwait
Tamara Al Rabi • Country Regulatory Head
Haitham Saad Al-Zuhair • Regulatory Affairs Director
Janssen-Cilag, Saudi Arabia
Hassaan S Alwohaibi • Director of Products Licensing Department - Executive Department of Licensing
Saudi Food and Drug Authority, Saudi Arabia
Ihab Attia • Regulatory Affairs Director - Middle East Affiliate
Eli Lilly (suisse) S.A., United Arab Emirates
Adele Choueiry • Head, Regulatory Affairs, Levant Region; Lebanon Regulatory Working Group Chair
Novartis , Lebanon
Paul Dearden • Director, Regulatory Policy & Intelligence
AbbVie, United Kingdom
Greg Jordinson, MSc • Associate Director, Global Regulatory Affairs
Janssen R&D, United Kingdom
Mounay Hussein Khafaja, PharmD, MSc • Regulatory Affairs Director & Regulatory Center of Excellence, IRWG Group Chair
Sarah Maqseed • Health Authority Advisors
KFDA Kuwait Drug and Food Control Administration, Kuwait
Samia Gamal Seleem, PharmD, RAC • Scientific office & Regulatory Affairs
Marloes van Bruggen, MS • Regulatory Program Manager
F.Hoffmann-La Roche Ltd., Switzerland
Nadine Otin •